Product
AAVAnc80-hOTOF
Aliases
AAVAnc80-hOTOF via Akouos Delivery Device
1 clinical trial
2 indications
Indication
Hearing Loss, SensorineuralIndication
BilateralClinical trial
A Phase 1/2 Trial of AAVAnc80-hOTOF Gene Therapy in Individuals With Sensorineural Hearing Loss Due to Biallelic Otoferlin Gene MutationsStatus: Recruiting, Estimated PCD: 2028-10-01